{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:53:22Z","timestamp":1794650002847,"version":"4.9.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201500006I"],"award-info":[{"award-number":["HHSN272201500006I"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40121-022-00605-z","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T15:02:17Z","timestamp":1645369337000},"page":"841-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-1680","authenticated-orcid":false,"given":"Stephen J.","family":"Balevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti M.","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Randell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Deye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Shotwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Liebman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cohen-Wolkowiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"key":"605_CR1","unstructured":"World Health Organization (WHO). World Malaria Report 2019. WHO web site. https:\/\/www.who.int\/publications\/i\/item\/9789241565721. Accessed 3 Nov 2020."},{"key":"605_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.bbagen.2014.02.009","volume":"1840","author":"LM Coronado","year":"2014","unstructured":"Coronado LM, Nadovich CT, Spadafora C. Malarial hemozoin: from target to tool. Biochim Biophys Acta. 2014;1840:2032\u201341. https:\/\/doi.org\/10.1016\/j.bbagen.2014.02.009.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"605_CR3","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1371\/journal.pctr.0020006","volume":"2","author":"F Mzayek","year":"2007","unstructured":"Mzayek F, Deng H, Mather FJ, et al. Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers. PLoS Clin Trials. 2007;2(1):e6. https:\/\/doi.org\/10.1371\/journal.pctr.0020006.","journal-title":"PLoS Clin Trials"},{"issue":"2","key":"605_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/014107689008300208","volume":"83","author":"PA Phillips-Howard","year":"1990","unstructured":"Phillips-Howard PA, West LJ. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. J R Soc Med. 1990;83(2):82\u20135. https:\/\/doi.org\/10.1177\/014107689008300208.","journal-title":"J R Soc Med"},{"issue":"2","key":"605_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijantimicag.2005.04.019","volume":"26","author":"R Wielgo-Polanin","year":"2005","unstructured":"Wielgo-Polanin R, Lagarce L, Gautron E, et al. Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil. Int J Antimicrob Agents. 2005;26(2):176\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.04.019.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"605_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/0961203318768884","volume":"27","author":"B Sunkara","year":"2018","unstructured":"Sunkara B, Roofeh D, Silver S, et al. The devil\u2019s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Lupus. 2018;27(8):1383\u20136. https:\/\/doi.org\/10.1177\/0961203318768884.","journal-title":"Lupus"},{"issue":"6","key":"605_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0961203314561667","volume":"24","author":"SM Abdel Galil","year":"2015","unstructured":"Abdel Galil SM. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report. Lupus. 2015;24(6):638\u201340. https:\/\/doi.org\/10.1177\/0961203314561667.","journal-title":"Lupus"},{"issue":"4","key":"605_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jps.20792","volume":"96","author":"AM Kaufmann","year":"2007","unstructured":"Kaufmann AM, Krise JP. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci. 2007;96(4):729\u201346. https:\/\/doi.org\/10.1002\/jps.20792.","journal-title":"J Pharm Sci"},{"issue":"3","key":"605_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/ers.12.26","volume":"6","author":"AM Taveira-DaSilva","year":"2012","unstructured":"Taveira-DaSilva AM, Moss J. Optimizing treatments for lymphangioleiomyomatosis. Expert Rev Resp Med. 2012;6(3):267\u201376. https:\/\/doi.org\/10.1586\/ers.12.26.","journal-title":"Expert Rev Resp Med"},{"key":"605_CR10","unstructured":"US Food and Drug Administration. End-of-Phase-2A Meetings. Guidance for Industry. FDA Web Site. https:\/\/www.fda.gov\/media\/72211\/download. Published September 2009. Accessed 4 Nov 2020."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00605-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00605-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00605-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T19:39:32Z","timestamp":1648496372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00605-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00605-z","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,20]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}